INTRODUCTION
Neurons in the adult mammalian CNS have only a limited capacity to regrow their axons after injury. It has been shown that axotomized CNS neurons are capable of regrowth in the presence of a permissive environment [1, 2] . This result suggested that the extrinsic environment of the damaged CNS does not have the capacity to support extensive axonal regeneration. Traumatic injury of the spinal cord is followed by robust glial reactions and formation of glial scar by reactive astrocytes [3] . The failure of injured CNS axons to regenerate have been attributed to the inhibitory cell surface and extracellular matrix (ECM) molecules that produced by mature oligodendrocytes and reactive astrocytes [4±6] . The glycosaminoglycan (GAG) side chains of proteoglycans (PGs), such as chondroitin sulfate (CS), are putative components of the ECM that may inhibit axonal regrowth and contribute to the nonpermissive properties of the injured CNS [7±9] . Recent reports have demonstrated that these matrix molecules can inhibit neurite outgrowth in vitro [10, 11] . Enzymatic removal or modi®cation of the GAG side chains of the PGs can abolish the inhibitory capacity of the ECM molecules [12] , suggesting that these side chains are involved in the inhibitory activity of the glial scar [7, 8] . Following peripheral nerve injury, it has been shown that soluble forms of CS are increased in the vicinity of the injured nerve [13] . Enzymatic degradation of CS increases the neurite-promoting properties of Schwann cell basal lamina [14] . Wang et al. [15] have reported that hemisection of the spinal cord in adult mice results in increased expression of CS in both the gray and white matter. However, it is unknown whether in vivo enzymatic digestion of CS can promote the axonal regeneration of the neurons in Clarke's nucleus (CN) after traumatic injury of the spinal cord.
Little is known about the role of nitric oxide synthase (NOS) on the axonal regeneration of injured CNS neurons. It has been suggested that lesion-induced expression of NOS is involved in the survival and axonal regeneration of the neurons in the spinal cord after injury [16] . Expression of NOS is induced in axotomized spinal motoneurons following spinal root avulsion. Axonal regeneration of injured spinal motoneurons can be promoted by implantation of a peripheral nerve (PN) graft, in which none of the regenerating neurons express NOS [17] . We have demonstrated that expression of NOS is induced in CN neurons after hemisection of the spinal cord [18] . The aim of this study is to examine whether enzymatic digestion of CS could promote the axonal regeneration of CN neurons into a PN graft after hemisection of the spinal cord. We have also investigated if NOS expression is involved in the axonal outgrowth of injured CN neurons.
MATERIALS AND METHODS
Adult female Spraque±Dawley rats (200±250 g) were anesthetized with i.p. ketamine (80 mg/kg) and xylazine (8 mg/kg). Under an operating microscope, a dorsal laminectomy was carried out and the T11 spinal segment was identi®ed. After opening the dura mater, a right hemisection was performed at T11 spinal level using a pair of spring scissors. A 15 mm segment of the autologous saphenous nerve (a branch of the sciatic nerve) was dissected together with the perineurium preserved. Immediately after the hemisection at T11, the PN segment was inserted into the lesion cavity. The distal end of the segment was placed blindly outside the spinal cord.
After hemisection of the spinal cord and implantation of PN graft, animals were divided into four groups. Animals in the ®rst group remained untreated to serve as the control (n 6). In the second group, a small piece of gelfoam soaked with 10 ìl vehicle (0.1 M PBS; n 6), was placed on top of the implantation site. Animals in the third group (n 3) received BDNF (Regeneron Pharmaceutical and Regeneron/Amgen Partners) at a dose of 1.7 ìg/day from osmotic minipumps (Alzet model 2002; infusion rate 0.5 ìl/h for 15 days) as described previously [19] . The pumps were replaced with new ones 15 days after the operation to allow continuous infusion of BDNF for the whole survival period. In the fourth group, a piece of gelfoam soaked with 10 ìl of either 1.0 (n 6), 2.5 (n 8), or 5.0 (n 6) units/ml Proteus vulgaris chondroitinase ABC lyase (Seikagaku Corporation, Japan) was placed on top of the implantation site. Following the surgical operation, the super®cial wound was closed with 5-0 sutures and surgical wound clips. The postoperative survival period of all the groups was 4 weeks.
Fluoro-Gold (FG) was used to label the CN neurons at the ®rst lumbar (L1) spinal segment that had regenerated their axons into the PN graft. Two days before sacri®ce, animals were re-anesthetized with i.p. ketamine (80 mg/ kg) and xylazine (8 mg/kg). The super®cial wound was opened and 0.5 ìl FG (Flurochrome, 5% in distilled water) was injected into the distal end of the PN graft using a Hamilton syringe.
Four weeks after the lesions, the animals were anesthetized with a lethal dose of xylazine and ketamine, and they were perfused intracardially with normal saline, followed by 400±500 ml ®xative containing 4% paraformaldehyde and 0.2% picric acid in 0.1 M phosphate buffer (pH 7.4). The L1 spinal cord was removed, immersion-®xed in fresh ®xative for 6 h, and then placed in 30% phosphate-buffered sucrose overnight. Cryosections were serially cut at 30 ìm and collected in PBS. Sections were ®rst observed under uorescent microscopy, and selected sections then proceeded to NADPH-diaphorase (NADPH-d) histochemistry.
To con®rm the enzymatic activity of chondroitinase ABC, horizontal cryostat sections from the implantation site were stained with an antibody against CS. The animals were either treated with PBS (n 3) or 2.5 units/ml chondroitinase ABC (n 3) following hemisection at T11 together with implantation of a PN graft. The postoperative survival period was 2 weeks. Sections (30 ìm) were preblocked with 2% normal goat serum with 0.1% Triton X-100 (Sigma) and then incubated at 48C for 48 h in a mouse anti-chondroitin sulfate monoclonal antibody (PharMingen) diluted 1:100 in PBS containing 2% normal goat serum with 0.1% Triton X-100. They were rinsed in PBS, and reacted with an FITC-tagged goat anti-mouse IgG (Zymed) diluted in PBS containing 10% normal goat serum for 30 min. After rinsing in PBS, sections were mounted on subbed slides and examined under a¯uorescent microscope. Control sections that did not receive the primary antibody were used to distinguish between speci®c and non-speci®c staining.
To determine whether the FG-labeled CN neurons also expressed NOS, selected L1 sections that contained FGlabeled CN neurons were incubated at 378C for 1 h in 10 ml 0.1 M Tris±HCl (pH 8.0) containing 10 mg NADPH (Sigma) and 2.5 mg nitroblue tetrazolium, and then counterstained with neutral red. We have shown that NADPH-d stained the same population of neurons in CN as neuronal NOS immunohistochemistry [18] .
To determine the proportion of regenerated CN neurons among the surviving neurons on the lesioned side, the number of FG-labeled CN neurons in 50 1-in-2 serial crosssections from L1 spinal segment was counted blindly under a¯uorescent microscope. The number of FG-labeled CN neurons was expressed as a percentage of the total number of CN neurons on the lesioned side. This percentage among groups was compared statistically using oneway ANOVA followed by Tukey-Kramer multiple comparisons test.
RESULTS
To con®rm that the FG-labeling in CN neurons was not due to diffusion of the dye, horizontal sections of the implantation site (T11) were examined under¯uorescent microscopy. The interneurons around the central canal of the spinal cord, being capable of regrowing their axons to a PN graft after axotomy, were clearly labeled by FG. No signs of FG diffusion could be observed on the sections (data not shown). The proximal end of the PN graft was integrated with the tissue of the injured spinal cord (Fig. 1a) .
On the lesion side at L1, there were no FG-labeled CN neurons in the animals with implantation of PN graft alone or sham treatment. In addition, there were no FG-labeled CN neurons observed in the animals with implantation of PN graft together with continuous infusion of BDNF. Administration of 2.5 units/ml chondroitinase ABC at the implantation site increased the percentage of FG-labeled CN neurons at L1 to 12.8%. Treatment with chondroitinase ABC at concentrations of 1.0 and 5.0 units/ml was associated with fewer FG-labeled CN neurons (5.8 and 2.0% respectively; Fig. 1b, Fig. 2 ). Statistical comparison between the groups treated with vehicle, BDNF and different concentrations of chondroitinase ABC showed no signi®-cant difference on the number of surviving CN neurons stained by neutral red on the lesioned side ( p . 0.05). Therefore, chondroitinase ABC only promoted the regeneration of CN neurons into a PN graft but did not enhance the survival of CN neurons after hemisection of the spinal cord.
CS immunoreactivity was localized at the junction of the PN graft and the tissue of the spinal cord. The immunoreactivity at the implantation site in the group treated with 2.5 units/ml chondroitinase ABC was lower than that in the control group 2 weeks after surgery (Fig. 1d,e) . These data demonstrated that chondroitinase ABC could digest the CS moiety of proteoglycan at the implantation site.
Double labeling with FG and NADPH-d histochemistry showed that retrogradely FG-labeled CN neurons did not express NOS. None of the NOS-positive CN neurons was labeled with FG (Fig. 1b,c) . The expression of NOS may not be involved in the axonal outgrowth of CN neurons into a PN graft.
DISCUSSION
There are no previous in vivo reports showing that enzymatic digestion of the components of glial scar could promote the axonal outgrowth of CN neurons following spinal cord traumatic injury. Our study demonstrated that implantation of PN graft alone or combined application of PN graft and BDNF could not stimulate the regeneration of neurons in CN four weeks after hemisection of the spinal cord. However, enzymatic degradation of the CS moiety at the implantation site promoted the axonal regeneration of CN neurons into a PN graft after the hemisection. We also showed that the regenerating CN neurons did not express NOS. Our results support the hypothesis that CS is inhibitory to axonal regeneration of CN neurons in the injured spinal cord. In addition, the expression of NOS might not be involved in axonal regrowth of the CN neurons.
Our prevoius study has demonstrated that implantation of PN graft or continuous infusion of BDNF can promote the survival of CN neurons after hemisection of the spinal cord [19] . Neither PN graft alone nor combined application of BDNF and PN graft, but treatment with chondroitinase ABC, promoted the axonal regeneration of CN neurons following the hemisection. These results suggest that the failure of axonal regeneration in the traumatized CNS is not due to lack of neuronal survival after injury, but rather the formation of scar at the leisoned site.
The immunoreactivity for CS was localized at the junction of the PN graft and the spinal cord. The immunoreactivity was lowered following treatment with chondroitinase ABC by 2 weeks after the surgical operation. We chose 2 weeks as the time point for studying the immunoreactivity because the period of enzymatic activity of chondroitinase might be very short in vivo. These data suggested that the chondroitinase remained active in lowering CS by 2 weeks in vivo. We hypothesized that the enzymatic activity of the chondroitinase was available at the time when axons cross the PN graft±spinal cord junction. Further experiments are reqiured to determine the relationship between the time courses of CS immunoreactivity and regrowth of the CN axons.
In the CNS, CS-PGs are thought to play an inhibitory role in axonal outgrowth, both during normal development and after traumatic injury. CS-PG has been found to be expressed both in regions of the developing CNS where axon pathways form [20] and in areas that axons avoid [21, 22] . Followang injury of the adult CNS with implantation of PN graft, up-regulation of CS-PG at the host/ transplant interface might block regeneration, whereas the levels of PGs were minimal in the successful transplants [23] . Ten days after hemisection of the spinal cord in the adult mice, there was a marked increase in CS-PG labeling in the parenchyma on either side of the lesion [15] . In the cortex, enzymatic digestion of PGs using chondroitinase ABC could promote laminin-mediated neurite outgrowth across the surface of glial scars [24] . The immunoreactivities for CS-PG were found predominantly in reactive glial cells after brain injury [9, 25] . After injury of the cerebellum, the increase in CS-PG immunoreactivity was transient, reaching a maximum at 7 days post-injury, and declining slowly thereafter [25] . The puri®ed inhibitor was a CS-PG with a molecular weight of 160±220 kDa and the inhibition was related to CS GAG moieties [8] . Our previous study showed that heparan sulphate in peripheral nerve bridge promoted axonal regeneration [26] . Here we demonstrated that enzymatic digestion of CS promoted the axonal regeneration of CN neurons after traumatic injury of the adult spinal cord in vivo. Taken together, these results support the hypothesis that the increased expression of CS may contribute to the failure of damaged CNS axons to regenerate extensively [5] .
The precise mechanism by which PGs prevent axonal outgrowth is unknown. In the case of chick brain collapsin, PGs induced paralysis of growth cones [27] . The inhibitory PGs might elicit growth cone stopping and/or turning, resulting in a reduction of neurite length or a decrease in the growth rate [9] . In addition, PGs might exert their inhibitory effects directly, by binding to the neurons, or indirectly, by hindering the outgrowth-promoting molecules such as laminin. PGs might bind to a speci®c neuronal receptor for their epitopes. Indeed it was demonstrated that the action of GAGs was mediated by speci®c binding to neuronal receptors, followed by internalization and elevation of intracellular Ca 2 [28, 29] . On the other hand, CS might indirectly inhibit axonal outgrowth by shielding growth-promoting sites in the ECM, such as laminin, thereby limiting their effects on promoting neurite outgrowth. Our study only provided results that chondroitinase ABC promoted the axonal regeneration of neurons in CN after spinal cord injury. Further experiments are needed to study the precise role and mechanism of CS on axonal outgrowth of injured CN neurons. We demonstrated that the FG-labeled CN neurons were NOS-negative. Although this ®nding repeatedly occurred in animals treated with chondroitinase ABC, we could not rule out the possibility that the absence of FG and NOS double labeling was because a very low proportion of neurons was stained with either method. It was thought that lesion-induced NOS expression might be involved in the survival and axonal regeneration of spinal motoneurons. After ventral root avulsion, the motoneurons that regenerate into a PN graft did not express NOS, whereas the motoneurons that express NOS failed to regenerate [17] . Our result seems consistent with these studies, suggesting that NOS may not support the regeneration of injured neurons in the spinal cord. We have shown that inhibiting the expression of NOS potentiates the neuroprotective functions of PN graft and neurotrophic factors [30] . In future studies, it is important to examine whether inhibiting the expression of NOS can further promote the outgrowth-promoting ability of chondroitinase ABC on injured CN neurons. A better understanding of the interactions between growing neurites, growth-inhibitory molecules and expression of NOS may provide important insights into mechanisms which lead to regenerative failure in the adult spinal cord after traumatic injury.
CONCLUSION
The present study examined whether enzymatic digestion of CS promoted the axonal regrowth of CN neurons into a PN graft after injury of the spinal cord. We showed that application of chondroitinase ABC at the implantation site signi®cantly enhanced the regrowth of CN neurons. These data suggested that CS might be inhibitory to the regeneration of injured CN neurons.
